These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22573053)

  • 1. Survey of compliance with oseltamivir phosphate therapy in Japan.
    Ushijima K; Higuchi S; Fujimura A
    Am J Ther; 2009; 16(1):8-10. PubMed ID: 22573053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Compliance and safety of oseltamivir treatment in children and infants less than one year of age].
    Tasher D; Bishop B; Stein M; Somekh E
    Harefuah; 2012 Aug; 151(8):450-4, 499. PubMed ID: 23350287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance to oseltamivir and subsequent occurrence of self-reported adverse drug reactions among nursery and primary school children following exposure to Influenza A(H1N1)v.
    van Velzen E; Hutchinson S; Penrice G; Ahmed S; McMenamin J
    Scott Med J; 2011 May; 56(2):120. PubMed ID: 21670140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety profile of oseltamivir during the 2009 influenza pandemic.
    Donner B; Bader-Weder S; Schwarz R; Peng MM; Smith JR; Niranjan V
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):532-43. PubMed ID: 21448900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
    Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
    Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
    Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
    J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course of fever following influenza virus infection in children treated with oseltamivir.
    Suzuki E; Ichihara K
    J Med Virol; 2008 Jun; 80(6):1065-71. PubMed ID: 18428131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir: cutaneous and neurological adverse effects in children.
    Prescrire Int; 2006 Oct; 15(85):182-3. PubMed ID: 17128526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
    Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
    N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza and oseltamivir phosphate (Tamiflu) in infants: what you need to know.
    Mortada M; Neuenschwander P; Tekko SS
    Pediatr Nurs; 2014; 40(1):16-20. PubMed ID: 24757915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of Japanese infants younger than 3 months who were treated with oseltamivir for influenza: safety of oseltamivir treatment.
    Morioka I; Nonoyama S; Tanaka-Taya K; Ihara T; Sugaya N; Ueta I; Kumagai T; Okada K; Hosoya M; Okabe N; Morishima T;
    Scand J Infect Dis; 2012 Aug; 44(8):605-9. PubMed ID: 22497443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral therapy and prophylaxis for influenza in children.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Satoh I; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2006 Aug; 43(4):439-44. PubMed ID: 16838232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir treatment for children showing abnormal behavior during influenza virus infection.
    Tanabe T; Hara K; Nakajima M; Shimakawa S; Tamai H
    Brain Dev; 2010 Jun; 32(6):440-4. PubMed ID: 19200672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children.
    Kubo T; Nishimura H
    Phytomedicine; 2007 Feb; 14(2-3):96-101. PubMed ID: 17141491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
    Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
    Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.
    Muñoz FM; Anderson EJ; Deville JG; Clinch B; Kamal MA
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):531-40. PubMed ID: 26042486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children.
    Sugaya N; Shinjoh M; Mitamura K; Takahashi T
    J Infect; 2011 Oct; 63(4):288-94. PubMed ID: 21722665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.